These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2939853)

  • 1. [Increasing the local concentration of fibrinolysin and thrombolysis rate using magnetic fluid in a model of occlusive thrombosis].
    Rusetskiĭ AN; Ruuge EK; Meertsyk FE
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(1):89-93. PubMed ID: 2939853
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
    Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM
    Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thrombolytic effect of miniplasmin in a canine model of femoral artery thrombosis.
    Fu J; Ren J; Zou L; Bian G; Li R; Lu Q
    Thromb Res; 2008; 122(5):683-90. PubMed ID: 18328540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport processes in fibrinolysis and fibrinolytic therapy.
    Blinc A; Francis CW
    Thromb Haemost; 1996 Oct; 76(4):481-91. PubMed ID: 8902982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience in using plasmapheresis in patients with thrombo-obliterative diseases of the vessels of the leg].
    Abdullaev EG; Babyshin VV
    Vestn Khir Im I I Grek; 1989 Oct; 143(10):126-7. PubMed ID: 2631336
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolysis.
    Fearnley GR
    Adv Drug Res; 1973; 7():107-63. PubMed ID: 4280240
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental basis for using artificial magnetic fields in surgery].
    Demetskiĭ AM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (1):43-6. PubMed ID: 7222510
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a constant magnetic field on blood circulation after experimental operations on arteries of the extremities].
    Lud GV
    Vestn Khir Im I I Grek; 1986 Sep; 137(9):87-8. PubMed ID: 3538626
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemorheologic therapy in peripheral arterial occlusive disease].
    Kiesewetter H; Jung F
    Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of in situ fibrin degradation in pathologic thrombi.
    Francis CW; Markham RE; Marder VJ
    Blood; 1984 May; 63(5):1216-24. PubMed ID: 6231967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural inhibitors of fibrinolysis and thrombohemorrhagic phenomena].
    Moriau M
    Pathol Eur; 1969; 4():Suppl 1:9-286. PubMed ID: 4244510
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamic aspects of magnetically-guided drug transport].
    Rusetskiĭ AN; Ruuge EK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):85-90. PubMed ID: 6732938
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospects for using local UHF-hyperthermia combined with radiation therapy for malignant tumors].
    Lopatin VF; Dedenkov AN
    Med Radiol (Mosk); 1979 Sep; 24(9):9-12. PubMed ID: 502796
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
    Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of nonuniting osteotomies with pulsating electromagnetic fields. A controlled animal experiment.
    Enzler MA; Sumner-Smith G; Waelchli-Suter C; Perren SM
    Clin Orthop Relat Res; 1984; (187):272-6. PubMed ID: 6744729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alternating magnetic field in the treatment of various eye diseases of vascular etiology].
    Vaĭnshteĭn ES; Zobina LV; Gurtovaia EE
    Oftalmol Zh; 1981; 36(6):325-8. PubMed ID: 7312261
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary report on experimental observation of the effects of magnetic field and "Natural Copper" on fracture healing.
    Liu HQ; Zhu X; Zhao SL; Yu M; Meng XM
    Acta Acad Med Wuhan; 1984; 4(4):220-8. PubMed ID: 6527846
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a low-frequency alternating magnetic field in the complex treatment of patients with functional diseases of the larynx].
    Demchenko EV
    Vestn Otorinolaringol; 1988; (3):42-7. PubMed ID: 3212866
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of a low-frequency alternating magnetic field on the course of pyrogenal-induced fever].
    Shishlo MA; Nikulina LA; Kirichenko NB
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (5):54-5. PubMed ID: 6506567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.